|Proteome Sciences plc -- UK Stock|| |
GBp 3.15 0.02 0.63%
Head of Projects and Production - Proteome Sciences RandD
Dr. Josef Schwarz is Head Projects Production, Proteome Sciences RD of Proteome Sciences PLC. Joseph Schwarz joined the Group in summer 2002 when Xzillion, the former proteomics division of Aventis Research and Technologies, was acquired by Proteome Sciences plc. He worked for AventisHoechst Research and Technologies for 6 years, initially as head of mass spectrometry and later as research collaboration project leader. He was instrumental in the establishment of the integrated high throughput 2DEmass spectrometry proteomics platform at the Frankfurt research facility. Josef Schwarz holds a PhD in organic chemistrymass spectrometry from the Technical University of Berlin, Germany and a MBA from the University of Durham, UK. He is an author of a number of publications and coinventor of patents.
Executive Since 2011 MBA
44 19 3286 5065 http://www.proteomics.com
The company has return on total asset (ROA)
of (20.17) %
which means that it has lost $20.17 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (16.4) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 8.93 M in total debt. Proteome Sciences plc has Current Ratio of 0.38 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Proteome Sciences plc, a life sciences company, engages in the research and development of biomarkers. Proteome Sciences plc (PRM) is traded on London Stock Exchange in UK. It is located in Cobham, KT EP and employs 35 people.